Latest News and Press Releases

SAN FRANCISCO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA) today announced that Sean Bohen, M.D., President and Chief Executive Officer,...

New York, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Non-Volatile Memory Express (NVMe) Industry" -...

REHOVOT, Israel, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Purple  Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and...

Thermo Fisher Scientific to provide biologic manufacturing expertise and scale-up capacity to manage the clinical supply of eblasakimab for future Phase 3 studies A high concentration formulation of...

The second Expanded Access patient (EA2) demonstrated additional clinical improvement in the Expanded Disability Status Scale (EDSS), a FDA recognized standard clinical outcome assessment score NEW...

CALGARY, Alberta, Jan. 03, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...

- 496 BTC mined in December 2022 -- 4.5 EH/s and 188 MW operating capacity at year end -- BTC-backed loan facility paid off in full - This news release constitutes a “designated news release” for...

WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “us,” “our,” “GEG” or “Great Elm,”) (NASDAQ: GEG), an investment management company, today announced its sale of a...

REDWOOD CITY, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...

Ottawa, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The global orthopedic braces and supports market size will reach at USD 5.64 billion in 2023. Orthopedic braces and supports are used in the field of...